Cargando…

Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies

BACKGROUND: The development of brain metastases is a common problem in patients diagnosed with non-small cell lung carcinoma (NSCLC). Technological advances in surgery and radiotherapy have allowed greater local control. Moreover, the emergence of targeted therapies and immunotherapy with greater ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Margarita, Hernanz, Raúl, Vallejo, Carmen, Guerrero, Leonardo, Mielgo, Xabier, Lopez, Ana, Trujillo-Reyes, Juan Carlos, Couñago, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518765/ https://www.ncbi.nlm.nih.gov/pubmed/36186687 http://dx.doi.org/10.5603/RPOR.a2022.0050

Ejemplares similares

Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
por: Aguado, Carlos, et al.
Publicado: (2022)

Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
por: Sereno, María, et al.
Publicado: (2021)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)

Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

Tsunami of immunotherapy reaches mesothelioma
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2022)

New perspectives in the management of small cell lung cancer
por: Pangua, Cristina, et al.
Publicado: (2022)

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
por: Olmedo, Maria Eugenia, et al.
Publicado: (2022)

International Conference on Classical Nova Explosions
por: Hernanz, Margarita, et al.
Publicado: (2002)

Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Lung cancer screening, what has changed after the latest evidence?
por: Trujillo-Reyes, Juan Carlos, et al.
Publicado: (2020)

Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
por: Aguado, Carlos, et al.
Publicado: (2022)

Coronavirus disease 2019 and lung cancer: where are we?
por: Ocanto, Abrahams, et al.
Publicado: (2023)

Interobserver variability in gross tumor volume contouring in non-spine bone metastases
por: de la Pinta, Carolina, et al.
Publicado: (2022)

Bone Metastases: An Overview
por: Macedo, Filipa, et al.
Publicado: (2017)

GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours
por: Rico, Mikel, et al.
Publicado: (2021)

FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes
por: Palma-Lara, Icela, et al.
Publicado: (2021)

On the contribution of classical novae to the $^{26}Al$ content of the Galaxy
por: Hernanz, M, et al.
Publicado: (2006)

Immunotherapy in non-small cell lung cancer: Update and new insights
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Brain metastases: Single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: A retrospective study
por: de la Pinta, Carolina, et al.
Publicado: (2020)

Beyond Classic Anastomoses Training Models: Overview of Aneurysm Creation in Rodent Vessel Model
por: García Feijoo, Pablo, et al.
Publicado: (2022)

An overview of reviews on strategies to reduce health inequalities
por: Garzón-Orjuela, Nathaly, et al.
Publicado: (2020)

High tumor burden in non-small-cell lung cancer: A review of the literature
por: Cabezón-Gutiérrez, Luis, et al.
Publicado: (2022)

Clinico-pathological and prognostic overview of metastasizing ameloblastoma: An overview of the systematic reviews
por: Sarode, Gargi, et al.
Publicado: (2023)

GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer
por: Rodríguez De Dios, Núria, et al.
Publicado: (2022)

Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
por: Barros, José Máximo, et al.
Publicado: (2021)

Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)

Classical and quantum physics of isolated horizons: a brief overview
por: Ashtekar, Abhay
Publicado: (1999)

Hallucinations in the classical Indian system of Ayurveda: A brief overview
por: Balsavar, Anuradha, et al.
Publicado: (2014)

Diversity in the bone marrow niche: Classic and novel strategies to uncover niche composition
por: Sánchez‐Lanzas, Raúl, et al.
Publicado: (2022)

Are all prostate cancer patients "fit" for salvage radiotherapy?
por: González-San Segundo, Carmen, et al.
Publicado: (2020)

Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
por: Couñago, Felipe, et al.
Publicado: (2019)

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
por: Fernández, Castalia, et al.
Publicado: (2022)

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
por: Ferns, Debbie M., et al.
Publicado: (2016)

Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sv6tgis9tqktsf01m6ldfchhpd